INTRODUCTION {#S1}
============

Oscillatory Ca^2+^ signaling is a fundamental control process utilized by hormones and other agonists linked to the second messenger inositol 1,4,5-trisphospate (IP~3~). Stimulus strength is typically encoded by increasing the frequency of cytosolic Ca^2+^ (\[Ca^2+^\]~i~) oscillations. For example, in hepatocytes, baseline-separated \[Ca^2+^\]~i~ oscillations with an extended frequency range (seconds to many minutes) provide fine control of metabolic output over log-order hormone dose ranges ([@R1]; [@R8]; [@R18]; [@R26]). Despite their critical importance, the mechanisms underlying IP~3~-dependent \[Ca^2+^\]~i~ oscillations have not been fully elucidated ([@R2]; [@R6]; [@R15]; [@R22]; [@R23]). There are two distinct classes of apparently opposing hypotheses that are very difficult to distinguish experimentally: Ca^2+^ excitability models in which Ca^2+^ oscillations occur independent of IP~3~ oscillations and cross-coupling models whereby IP~3~ oscillations are required to drive periodic Ca^2+^ release and reuptake.

In Ca^2+^ excitability hypotheses, feedback regulation by Ca^2+^ release from the ER gives rise to oscillations in \[Ca^2+^\]~i~, with IP~3~ serving as an upstream trigger that does not need to oscillate itself (i.e., \[Ca^2+^\]~i~ oscillations can occur at constant \[IP~3~\]). The complex regulatory properties of the IP~3~ receptor Ca^2+^ release channel (IP~3~R) provided a specific mechanism for Ca^2+^ excitability of the ER ([@R3]; [@R7]). Feedback activation through \[Ca^2+^\]~i~ can causethe coordinated opening of IP~3~Rs and regenerative Ca^2+^ release from the ER via a Ca^2+^-induced Ca^2+^ release (CICR) mechanism, whereas delayed negative feedback by Ca^2+^ can result in the subsequent closing of IP~3~Rs and the return of \[Ca^2+^\]~i~ to baseline through the action of Ca^2+^ pumps ([@R4]; [@R22]; [@R25]). Thus, the sequential Ca^2+^-dependent activation and inactivation of IP~3~Rs can give rise to an autonomous oscillator that generates periodic \[Ca^2+^\]~i~spikes. Mathematical models based solely on IP~3~R kinetics yield \[Ca^2+^\]~i~ oscillations that occur at high frequency (seconds) and within a limited range of \[IP~3~\] or phospholipase-C (PLC) activity ([@R3]). Experimental evidence supports the existence of such a fast \[Ca^2+^\]~i~ oscillator mechanism in some cell types, activated by a static increase in average \[IP~3~\]([@R12]; [@R13]; [@R20]).

In many other cell types, however, \[Ca^2+^\]~i~ signals evoked with physiologically relevant agonist doses have much lower frequencies (of the order of minutes) than the oscillations based on periodic IP~3~R opening ([@R1]; [@R9]; [@R16]; [@R17]; [@R18]; [@R26]). In hepatocytes, the slow \[Ca^2+^\]~i~ oscillations observed in hormone-stimulated intact cells revert to a higher frequency spiking pattern when studied at fixed \[IP~3~\] after cell permeabilization ([@R7]). Thus, other mechanisms may be superimposed on the basic Ca^2+^ excitability model to produce the broad distribution of agonist-evoked \[Ca^2+^\]~i~ oscillation frequencies observed experimentally. This can provide more efficient encoding of the strength of the extracellular stimulus into intracellular Ca^2+^ signaling ([@R17]).

Cross-coupling hypotheses postulate that the dynamics of IP~3~ and Ca^2+^ are mutually destabilizing, resulting in coupled oscillations of both messengers. In the most widely discussed model, stimulation of PLC by Ca^2+^ provides the positive feedback to generate a rapid burst of IP~3~ formation ([@R9]; [@R15]; [@R17]; [@R26]). Termination of Ca^2+^ release can occur by negative feedback processes such as Ca^2+^ inactivation of IP~3~R, elimination of IP~3~ by Ca^2+^activation of inositol 1,4,5-trisphosphate 3-kinase (ITPK), or inhibition of receptor-stimulated PLC by protein kinase C (PKC). Thus, Ca^2+^-dependent feedback on either PLC, ITPK, or PKC, alone or in combination, has the potential to generate oscillations in \[IP~3~\] and drive \[Ca^2+^\]~i~ spiking ([@R17]).

Consistent with cross-coupling models, \[Ca^2+^\]~i~ spiking has been shown to be accompanied by synchronous fluctuations in IP~3~ or phosphatidylinositol 4,5-bisphosphate levels in intact cells ([@R9]; [@R10]; [@R14]; [@R24]). This may be an indication that IP~3~-Ca^2+^ cross-coupling is involved in the regulation of \[Ca^2+^\]~i~ oscillations. However, an alternative interpretation would be that the IP~3~ fluctuations are an epiphenomenon mediated by Ca^2+^-dependent changes in IP~3~ metabolism and are nonessential for generating \[Ca^2+^\]~i~ oscillations ([@R5]; [@R21]). We have taken a different approach from trying to measure IP~3~ oscillations and correlate \[IP~3~\] changes with \[Ca^2+^\]~i~ oscillations, focusing instead on modifying IP~3~ dynamics with a genetically encoded IP~3~ buffer designed to function within the physiological range of \[IP~3~\]. The recombinant cytosolic IP~3~ buffer was constructed by the in-frame fusion of the N-terminal 620 amino acids of the type-I IP~3~R to the C terminus of green or red fluorescent protein (GFP-LBD or DsRed-LBD). Previous studies have shown that the N terminus of the IP~3~R expressed in *E. coli* can bind to IP~3~ with similar affinity to native IP~3~R ([@R27]).

Chemical Ca^2+^ buffers and recombinantly expressed Ca^2+^-binding proteins have been successfully employed to investigate the role of Ca^2+^ dynamics in numerous processes. IP~3~-binding proteins should prove equally useful to probe the role of IP~3~ dynamics in generating Ca^2+^ spikes. The expression of GFP-LBD is expected to slow the kinetics of agonist-evoked IP~3~ turnover without modifying the free steady-state \[IP~3~\]. Moreover, our modeling studies demonstrate that an IP~3~ buffer allows us to go beyond determining the causality between \[IP~3~\] and \[Ca^2+^\]~i~ oscillations; it is also an ideal experimental tool to distinguish between positive- versus negative-feedback effects of Ca^2+^ on IP~3~ metabolism in controlling the generation of oscillatory Ca^2+^ signals ([@R17]).

The data presented here show that GFP-LBD can bind IP~3~ and decrease the rate of IP~3~ rise during agonist stimulation, which disrupts \[Ca^2+^\]~i~ spikes in COS cells and primary hepatocytes. This perturbation of Ca^2+^ signaling was due to the ability of GFP-LBD to bind IP~3~, because a mutant that does not bind IP~3~ had no effect on agonist-induced \[Ca^2+^\]~i~ responses. Increasing the level of GFP-LBD expression correlated with a loss of repetitive Ca^2+^ spiking and the appearance of distorted \[Ca^2+^\]~i~ responses with slower kinetics and smaller amplitudes. These data suggest that \[IP~3~\] increased to a level sufficient to activate the IP~3~R but lacked a self-amplifying mechanism required for robust spikes of Ca^2+^ release and propagation of intracellular \[Ca^2+^\]~i~ waves. Finally, introducing an IP~3~ buffer into a mathematical model based on the positive feedback of Ca^2+^ on PLC reproduced the experimental data. Taken together, these findings provide strong evidence that dynamic fluctuations of IP~3~ are an essential component in the generation of \[Ca^2+^\]~i~ spikes and propagation of intracellular Ca^2+^ waves.

RESULTS {#S2}
=======

Expression of GFP-LBD in COS Cells {#S3}
----------------------------------

The properties of GFP-LBD were determined in COS cells transiently transfected with either GFP alone, GFP-LBD, or a nonbinding mutant of GFP-LBD, with a single amino acid substitution in the IP~3~-binding site (GFP-R265QLBD; [@R27]). Western blot analysis of cells transfected with GFP-LBD or GFP-R265QLBD revealed a band at\~100 kDa, which corresponds to the full-length fusion protein([Figure S1A](#SD1){ref-type="supplementary-material"}). Confocal images of COS cells expressing GFP-LBD or GFP-R265QLBD revealed a cytosolic distribution, similar to that observed with GFP ([Figure S1B](#SD1){ref-type="supplementary-material"}). Permeabilization of the plasma membrane with digitonin resulted in rapid loss of the GFP fusion proteins, suggesting they are not bound to cytoskeletal elements or organelles.

Although GFP-LBD appeared to be freely diffusible, it could potentially interact with endogenous proteins, including plasma membrane and intracellular ion channels, and thereby modify agonist-induced Ca^2+^ influx and/or ER Ca^2+^ content. To test these possibilities, COS cells expressing GFP, GFP-LBD, or GFP-R265QLBD were incubated in Ca^2+^-free medium and the ER Ca^2+^ stores were released by treatment with 50 μM cyclopiazonic acid (CPA), followed by addition of 1.5 mM CaCl~2~ to measure store-operated Ca^2+^ influx ([Figures S1C--S1E](#SD1){ref-type="supplementary-material"}). GFP-LBD did not affect the size of the Ca^2+^ store, monitored by the rate and magnitude of CPA-induced Ca^2+^ release, and did not alter the rate or amplitude of Ca^2+^ influx elicited by subsequent Ca^2+^ add back ([Figures S1C--S1E](#SD1){ref-type="supplementary-material"}). Similar results were obtained with the purinergic agonist ATP. GFP-R265QLBD also had no effect on intracellular Ca^2+^ release or Ca^2+^ influx ([Figures S1F and S1G](#SD1){ref-type="supplementary-material"}). Finally, there was no effect of GFP-LBD on resting \[Ca^2+^\]~i~, indicating that it did not alter basal \[Ca^2+^\]~i~ homeostasis in the absence or presence of extracellular Ca^2+^ ([Figures S1D and S1H](#SD1){ref-type="supplementary-material"}). Similar results were obtained in hepatocytes ([Figure S2A](#SD1){ref-type="supplementary-material"}).

Because the intracellular concentration of the IP~3~ buffer is an important parameter for our analysis, we used a standard curve constructed with recombinant GFP to estimate the cytoplasmic concentration of each fusion protein on a cell-by-cell basis, as described previously ([@R17]). The mean levels of intracellular expression in COS cells for GFP-LBD and GFP-R265QLBD were similar (13 ± 1 μM and 12 ± 1 μM, respectively), whereas GFP alone was expressed at somewhat higher levels (22 ± 1 μM; see [Table S1](#SD1){ref-type="supplementary-material"}). As expected, there was an increase in the amount of total IP~3~ binding measured in lysates prepared from populations of COS cells transfected with GFP-LBD compared to GFP alone (79 ± 6 versus 20 ± 1 fmoles of IP~3~/mg cell protein, respectively, at 9.6 nM ^3^H-IP~3~).

These data demonstrate that the ligand-binding domain of GFP-LBD is expressed in the correct confirmation and is able to bind IP~3~. In addition, GFP-LBD does not modify the activity of plasma membrane Ca^2+^ channels, the size of internal Ca^2+^ stores, or the basal levels of \[Ca^2+^\]~i~.

GFP-LBD Blocks Agonist-Induced \[Ca^2+^\]~i~ Oscillations in COS Cells {#S4}
----------------------------------------------------------------------

COS cells were transiently transfected with either GFP-LBD or GFP, and the \[Ca^2+^\]~i~ responses to ATP stimulation at submaximal (1 μM) and then maximal (100 μM) doses were monitored with fura-2. Data from both expressing and nonexpressing cells were recorded simultaneously from the same microscope field. [Figure 1](#F1){ref-type="fig"} shows representative single-cell Ca^2+^ traces from coverslips transfected with either GFP ([Figures 1A and 1B](#F1){ref-type="fig"}) or GFP-LBD ([Figures 1C and 1D](#F1){ref-type="fig"}); in each case, the top panels show responses for untransfected cells from the same field as the transfected cell responses shown in the middle panels. Data are summarized in [Figures 1E and 1F](#F1){ref-type="fig"}. The addition of 1 μM ATP elicited periodic, baseline-separated \[Ca^2+^\]~i~ oscillations in \>90% of the COS cells that did not express the transgene ([Figures 1A and 1C](#F1){ref-type="fig"}) or expressed only GFP ([Figure 1B](#F1){ref-type="fig"}). The kinetics and amplitude of these \[Ca^2+^\]~i~ oscillations remained constant for the 10 min stimulation period and were not affected by the expression of GFP. By contrast, expression of GFP-LBD eliminated baseline-separated \[Ca^2+^\]~i~ oscillations in response to submaximal ATP; instead, a slow monophasic increase in \[Ca^2+^\]~i~ was observed ([Figure 1D](#F1){ref-type="fig"}). The amplitude ([Figure 1E](#F1){ref-type="fig"}) and rate of \[Ca^2+^\]~i~ increase ([Figure 1F](#F1){ref-type="fig"}) in these cells were significantly lower following submaximal ATP stimulation when compared to nonexpressing or GFP-positive cells.

Maximal ATP concentrations (100 μM) evoked a sustained increase in \[Ca^2+^\]~i~ in both expressing and nonexpressing COS cells transfected with either GFP or GFP-LBD ([Figure 1](#F1){ref-type="fig"}). The mean amplitude and rate of rise of these \[Ca^2+^\]~i~ increases were larger than those observed with 1 μM ATP ([Figures 1E and 1F](#F1){ref-type="fig"}). There were no significant differences between any of the groups in the amplitude of the \[Ca^2+^\]~i~ increase at 100 μM ATP, indicating that, with sufficient stimulation, enough IP~3~ could be generated to overcome the effect of the recombinant IP~3~ buffer. The mean rate of \[Ca^2+^\]~i~ increase in GFP-LBD-expressing cells was slower than any of the control groups, but this parameter was variable in the presence of GFP-LBD and was not statistically significant.

To test whether the lack of baseline-separated \[Ca^2+^\]~i~ oscillations in GFP-LBD-expressing COS cells was due to a shift in the effective ATP sensitivity, we carried out dose-response studies in these cells ([Figure 1H](#F1){ref-type="fig"}). However, \[Ca^2+^\]~i~ oscillations were not observed at any dose of ATP up to the maximum that gave a sustained \[Ca^2+^\]~i~ increase equivalent to that in control cells. Instead, low-amplitude monophasic \[Ca^2+^\]~i~ in creases were observed, the amplitude of which increased in a dose-dependent manner. Frequency-modulated \[Ca^2+^\]~i~ oscillations with similar amplitude and kinetics to control cells were observed over the effective ATP dose range in nonexpressing COS cells and cells expressing the nonbinding mutant R265QLBD ([Figures 1G and 1I](#F1){ref-type="fig"}). Thus, the suppression of agonist-induced \[Ca^2+^\]~i~ oscillations is a fundamental consequence of IP~3~ binding by GFP-LBD and not just due to a shift in the effective free \[IP~3~\].

Taken together, these data demonstrate that GFP-LBD does not prevent agonist-induced mobilization of Ca^2+^ from intra-cellular stores, even though it eliminates the ability of COS cells to generate \[Ca^2+^\]~i~ oscillations. The monotonic \[Ca^2+^\]~i~ increase evoked by agonist stimulation ([Figures 1D and 1H](#F1){ref-type="fig"}) indicates that IP~3~ levels were sufficient to activate the IP~3~R but lacked a positive feedback mechanism required for rapid Ca^2+^ mobilization.

GFP-LBD Suppresses \[Ca^2+^\]~i~ Oscillationsin Hepatocytes {#S5}
-----------------------------------------------------------

Hepatocytes provide one of the most well-characterized examples of frequency-modulated \[Ca^2+^\]~i~ oscillations in primary cells and tissues, where they play a key role in the regulation of hepatic metabolism ([@R1]; [@R8]; [@R22]). [Figure 2](#F2){ref-type="fig"} shows the effects of GFP-LBD expression on hormone-stimulated \[Ca^2+^\]~i~ signaling in primary cultures of rat hepatocytes. [Figure 2A](#F2){ref-type="fig"} shows representative single-cell \[Ca^2+^\]~i~ traces from hepatocytes expressing GFP or different levels of GFP-LBD. GFP-LBD-positive cells were divided into low- and high-expressing cells using a cutoff that corresponded to a calculated intracellular GFP concentration of 10 μM. The effects of GFP or GFP-LBD on the pattern of hormone-evoked \[Ca^2+^\]~i~ responses are summarized in [Figure 2B](#F2){ref-type="fig"}.

Stimulation of GFP-expressing hepatocytes with vasopressin (VP) induced repetitive \[Ca^2+^\]~i~ spiking that increased in frequency in a dose-dependent manner until a sustained plateau of \[Ca^2+^\]~i~ was achieved ([Figure 2A](#F2){ref-type="fig"}), consistent with the frequency modulation reported in previous studies ([@R18]; [@R26]). Submaximal VP (3 nM) evoked repetitive \[Ca^2+^\]~i~ spiking in 60% of the GFP-positive hepatocytes ([Figure 2B](#F2){ref-type="fig"}) with similar kinetic properties to those observed in untransfected hepatocytes ([@R18]). In both GFP- and GFP-LBD-expressing cells, the full scope of hormone-evoked Ca^2+^ responses was observed after hormone treatment, ranging from no response through repetitive oscillations to peak and plateau maximal increases in \[Ca^2+^\]~i~ ([Figure 2B](#F2){ref-type="fig"}). Importantly, in hepatocytes, baseline-separated \[Ca^2+^\]~i~ spiking could be elicited by VP in the presence of GFP-LBD. However, with increasing expression levels, GFP-LBD reduced the percentage of cells exhibiting repetitive baseline-separated \[Ca^2+^\]~i~ spikes ([Figure 2B](#F2){ref-type="fig"}). In addition, there was a marked broadening of the individual \[Ca^2+^\]~i~ transients with increasing levels of the GFP-LBD IP~3~ buffer ([Figure 2](#F2){ref-type="fig"}). In control (GFP-expressing) hepatocytes, the widths of consecutive spikes remained constant, averaging 22 ± 1 s (n = 27 cells). The spike duration was significantly longer in GFPLBD-expressing hepatocytes, averaging 50 ± 7 s (p \< 0.05; n = 21 cells). Moreover, the spike width in individual hepatocytes correlated positively with the calculated GFP-LBD concentrations (R^2^ = 0.58), whereas there was no correlation between spike width and GFP expression (R^2^ = 0.001; [Figure 2C](#F2){ref-type="fig"}).

In the presence of high GFP-LBD (\>10 μM), VP (1--3 nM) often evoked a single, broad \[Ca^2+^\]~i~ transient with a dramatically slower rising phase ([Figure 2A](#F2){ref-type="fig"}). The mean amplitude of these single-phasic \[Ca^2+^\]~i~ increases in the presence of GFP-LBD was not significantly different from GFP or nonexpressing controls ([Figure S2A](#SD1){ref-type="supplementary-material"}). Stepwise increases in VP concentration did not induce amplitude-modulated \[Ca^2+^\]~i~ increases in GFP-LBD-expressing hepatocytes similar to those observed in COS cells ([Figure 1](#F1){ref-type="fig"}). Nevertheless, the broadening of the \[Ca^2+^\]~i~ oscillations, slower rate of rise (see below), and switch to a slow single-phasic transient in the presence of GFP-LBD all provide evidence that IP~3~ dynamics are a component of the Ca^2+^ oscillator that generates baseline-separated Ca^2+^ spiking in hepatocytes.

In contrast to the baseline-separated \[Ca^2+^\]~i~ spikes in hepatocytes and COS cells, ATP stimulation of MDA MB231 breast cancer cells causes high-frequency sinusoidal-like Ca^2+^ oscillations ([Figure S3](#SD1){ref-type="supplementary-material"}). Expression of LBD in these cells did not affect the \[Ca^2+^\]~i~ oscillation frequency but did reduce the amplitude of both the initial spike and subsequent oscillations ([Figure S3](#SD1){ref-type="supplementary-material"}). Similar results were observed in the absence of extracellular Ca^2+^, showing that the effects were not secondary to Ca^2+^ influx. These data in MDA MB231 cells are consistent with the predicted effects of LBD on fast Ca^2+^ oscillations that can occur under conditions of constant \[IP~3~\], which typically occurs at high levels of PLC activation ([@R17]). Thus, the effect of IP~3~ buffering to suppress \[Ca^2+^\]~i~ oscillations is primarily associated with long-period, baseline-separated Ca^2+^ spiking, although this does not exclude a role for Ca^2+^ feedback on IP~3~ dynamics during faster oscillations.

The Effect of GFP-LBD on Intracellular \[Ca^2+^\]~i~ Waves {#S6}
----------------------------------------------------------

In many cell types, \[Ca^2+^\]~i~ oscillations are organized as intracellular Ca^2+^ waves. In hepatocytes, the Ca^2+^ waves begin at a discrete subcellular locus associated with the apical membrane and then propagate through the cell with constant velocity and amplitude ([@R19]). [Figure 2D](#F2){ref-type="fig"} shows time courses of \[Ca^2+^\]~i~ increase at discrete subcellular sites following VP stimulation in GFP-, low-GFP-LBD, or high-GFP-LBD-expressing hepatocytes. In each case, the green and red traces are the \[Ca^2+^\]~i~ increases from two subcellular regions in the same cell, separated by similar distances (see legend). The effects of GFP or GFP-LBD expression on the rates of Ca^2+^ wave propagation and rates of \[Ca^2+^\]~i~ rise are summarized in [Figures 2E and 2F](#F2){ref-type="fig"}. Submaximal agonist concentrations were defined as those that evoked oscillatory \[Ca^2+^\]~i~ responses in GFP and low-GFP-LBD-expressing cells, whereas maximal hormone doses evoked a peak and plateau \[Ca^2+^\]~i~ increase in all cells. In the GFP-expressing control cells, the rates of Ca^2+^ wave propagation and rates of Ca^2+^ rise were not significantly different between sub-maximal and maximal hormone concentrations (Figures [2E](#F2){ref-type="fig"} and [S2C](#SD1){ref-type="supplementary-material"}), consistent with our previous work showing that Ca^2+^ wave rates are independent of agonist dose ([@R19]). Increasing GFP-LBD expression from low to high levels progressively slowed the rates of Ca^2+^ wave propagation and decreased rates of Ca^2+^ rise elicited by submaximal hormone stimulation ([Figure 2](#F2){ref-type="fig"}). Maximal VP overcame the actions of low levels of GFP-LBD expression on both \[Ca^2+^\]~i~ oscillation parameters but only partially reversed the effects of high GFP-LBD expression ([Figures 2E and 2F](#F2){ref-type="fig"}). We also examined the effects of LBD on the kinetics of Ca^2+^ waves using a recombinant Ca^2+^-sensitive fluorescent protein, RGECO1 ([@R28]). This protein-based Ca^2+^ indicator is more slowly diffusible with lower buffering capacity compared to fura-2, so it should minimize alterations in Ca^2+^ wave kinetics that might derive from indicator effects on Ca^2+^ diffusion. Nevertheless, the expression of GFP-LBD still reduced Ca^2+^ wave velocity in a stimulus-strength-dependent manner in our studies using RGECO1 ([Figures S2B and S2C](#SD1){ref-type="supplementary-material"}). Thus, similar results were obtained with fura-2 and RGECO1: LBD decreased the rate of \[Ca^2+^\]~i~ rise even at subcellular resolution and slowed the propagation of Ca^2+^ waves. If \[Ca^2+^\]~i~ oscillations and waves were dependent only on Ca^2+^-feedback effects on Ca^2+^ release and reuptake, independent of oscillations in IP~3~, the Ca^2+^ dynamics should not be affected by the IP~3~ buffering effect of GFP-LBD.

Effect of LBD Expression on Ca^2+^ Responses Elicited by Slow Release of Caged IP~3~ {#S7}
------------------------------------------------------------------------------------

In order to further investigate whether the effects of IP~3~ buffering on hormone-induced \[Ca^2+^\]~i~ oscillations are indicative of a causative role for IP~3~ oscillations, we examined the response to a slow, continuous uncaging of IP~3~. Progressive uncaging of IP~3~ with low-intensity UV illumination in the absence of hormone resulted in a monophasic \[Ca^2+^\]~i~ rise after a brief delay, followed by a slow return to basal. [Figure 3](#F3){ref-type="fig"} shows representative traces from GFP- and GFP-LBD-expressing hepatocytes coexpressing RGECO1 for \[Ca^2+^\]~i~ measurement. Importantly, there was no effect of LBD on the rate of rise ([Figure 3C](#F3){ref-type="fig"}) or the peak amplitude ([Figure 3D](#F3){ref-type="fig"}) of the \[Ca^2+^\]~i~ increase elicited by uncaging IP~3~. One interpretation of these data is that once the \[IP~3~\] crosses a critical threshold, the primary driver of \[Ca^2+^\]~i~ increase is CICR, yielding a Ca^2+^ transient that is essentially autonomous from the slowly rising IP~3~ level. Despite the lack of effect of LBD on the rising phase, it significantly prolonged the \[Ca^2+^\]~i~ spike width ([Figure 3E](#F3){ref-type="fig"}), perhaps because it slows IP~3~ degradation. Once the \[Ca^2+^\]~i~ response to IP~3~ uncaging had returned to basal, the hepatocytes were subsequently challenged with 1 nM VP. In contrast to the results with IP~3~ uncaging, the rates of rise and peak amplitude of VP-induced Ca^2+^ transients were significantly decreased in the presence of LBD ([Figures 3C and 3D](#F3){ref-type="fig"}). These data demonstrate that the effect of the IP~3~ buffer is not simply a consequence of the rate of delivery of IP~3~ to the IP~3~R or the relative rates of IP~3~ R Ca^2+^ activation and inactivation. Instead, the data support a role for rapid dynamic modulation of IP~3~ levels specifically during hormone-induced \[Ca^2+^\]~i~ oscillations.

Effect of GFP-LBD on Agonist-Induced IP~3~ Increases {#S8}
----------------------------------------------------

The effects of GFP-LBD expression on intracellular IP~3~ levels were measured in populations of COS cells using an IP~3~ mass assay. Stimulation with submaximal ATP (1 μM) for 60 s increased total intracellular IP~3~ by 30% ± 1% above basal in control GFP-expressing cells, whereas IP~3~ accumulation in GFP-LBD-expressing cells was significantly greater at 69% ± 5% above basal (p \< 0.001). No significant difference in the basal levels of IP~3~ could be detected between the two cell populations. The higher accumulation of total IP~3~ in the presence of GFP-LBD is an expected consequence of IP~3~ buffering, because the IP~3~ buffer creates an additional cellular pool of sequestrated IP~3~.

To directly measure agonist-induced \[Ca^2+^\]~i~ and IP~3~ changes simultaneously by single-cell imaging, we used the recombinant IP~3~-sensitive biosensor IRIS-1 ([@R14]) together with the chemical Ca^2+^ indicator Indo-1. More than 90% of nontransfected COS cells responded to increasing ATP concentrations with frequency-modulated \[Ca^2+^\]~i~ spiking, whereas ATP induced only sporadic \[Ca^2+^\]~i~ spikes in the presence of IRIS-1 ([Figure S4](#SD1){ref-type="supplementary-material"}). This presumably reflects the effect of IP~3~ binding by IRIS-1 and is consistent with the sensitivity of COS cells to the IP~3~ buffering effects of GFP-LBD shown in [Figure 1](#F1){ref-type="fig"}. In order to examine the effect of the LBD buffer on IP~3~ dynamics, a DsRed-LBD construct was used so that IRIS-1 and LBD could be discriminated in cotransfected cells. Stimulation with maximal ATP caused a sustained increase in \[Ca^2+^\]~i~ and a robust rise in the IRIS-1 emission ratio in both DsRed and DsRed-LBD-expressing cells ([Figure S4C](#SD1){ref-type="supplementary-material"}). DsRed-LBD did not alter the magnitude of \[IP~3~\] increase induced by maximal ATP but slowed the rate of IP~3~ rise by about 5-fold ([Figures S4D and S4E](#SD1){ref-type="supplementary-material"}). As with our measurements of total IP~3~ formation, this is what is predicted for an IP~3~ buffer and serves to validate our approach using the LBD-expression constructs to modify the kinetics of IP~3~. In common with GFP-LBD, DsRed-LBD completely eliminated the occurrence of ATP-induced \[Ca^2+^\]~i~ oscillations in COS cells. Therefore, it was not possible to determine the effect of LBD on \[IP~3~\] dynamics during \[Ca^2+^\]~i~ spiking in these cells.

We also used IRIS-1 to examine the effects of DsRed-LBD expression on IP~3~ and \[Ca^2+^\]~i~ dynamics in hormone-stimulated hepatocytes ([Figure 4](#F4){ref-type="fig"}). At low levels of expression, IRIS-1 did not block \[Ca^2+^\]~i~ oscillations induced by submaximal VP but slowed the rising phase of the \[Ca^2+^\]~i~ spike (compare *DsRed* to *None* in [Figure 4C](#F4){ref-type="fig"}). This is expected because IRIS-1 is itself an IP~3~ buffer, but fortunately, its buffering effect is not sufficient to prevent the \[Ca^2+^\]~i~ oscillations in hepatocytes. Importantly, for each \[Ca^2+^\]~i~ spike, there was a parallel transient increase in the IRIS-1 emission ratio, indicating that Ca^2+^ and IP~3~ oscillations are synchronized in hepatocytes ([Figure 4A](#F4){ref-type="fig"}). The onset of the \[Ca^2+^\]~i~ and IP~3~ spikes appeared to occur simultaneously, whereas peak \[Ca^2+^\]~i~ was achieved while the IP~3~ level was still rising ([Figure 4B](#F4){ref-type="fig"}). The declining phase of the IP~3~ oscillations clearly lagged behind the relaxation of the \[Ca^2+^\]~i~ spike, and this was also apparent in the longer peak duration for IP~3~ ([Figures 4B and 4D](#F4){ref-type="fig"}). These data are consistent with positive feedback of Ca^2+^ on IP~3~ generation ([@R17]). Coexpression of the IP~3~ buffer DsRed-LBD with IRIS-1 slowed the rate of rise of \[IP~3~\], and this was accompanied by a slowing and broadening of the \[Ca^2+^\]~i~ spike ([Figure 4](#F4){ref-type="fig"}), similar to that observed with GFP-LBD (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Although DsRed-LBD expression slowed the rates of \[IP~3~\] increase evoked by both submaximal and maximal hormone stimulation, it did not alter the magnitude of these IP~3~ increases ([Figures 4E and 4F](#F4){ref-type="fig"}).

The data presented above demonstrate that the IP~3~ buffers DsRed-LBD and GFP-LBD act to suppress \[Ca^2+^\]~i~ oscillations by slowing the rate of increase in free IP~3~ and not by inhibiting IP~3~ formation. This is consistent with a key role for IP~3~ dynamics in driving \[Ca^2+^\]~i~ oscillations. It should be noted that IRIS-1 also partially inhibited agonist-induced \[Ca^2+^\]~i~ oscillations, even though it has a lower affinity for IP~3~ than the type-I IP~3~R used to derive the LBD-based IP~3~ buffers (Kd of 500 nM versus 40 nM, respectively; [@R14]; [@R27]). These findings indicate that IRIS-1 (and presumably other IP~3~ indicators) can interfere with Ca^2+^ dynamics by buffering agonist-induced changes in IP~3~.

Mathematical Modeling of IP~3~ Buffer Effects on IP~3~-Induced Ca^2+^ Oscillators {#S9}
---------------------------------------------------------------------------------

The data presented here provide evidence that oscillations of IP~3~ are essential for the generation of \[Ca^2+^\]~i~ spiking in many cell types. Different mechanisms for feedback regulation of IP~3~ levels by Ca^2+^ ions have been proposed that can result in coupled oscillations of \[IP~3~\] and \[Ca^2+^\]~i~: (1) inhibition of IP~3~ generation through PKC-mediated inactivation of agonist receptors or PLC; (2) Ca^2+^-mediated activation of IP~3~ removal by ITPK; and (3) activation of PLC by Ca^2+^ (see [@R17] and [@R20]). We have investigated how a molecular IP~3~ buffer (e.g., GFP-LBD) is predicted to affect these oscillator mechanisms by analyzing prototypical mathematical models for each mechanism. The models incorporate the regulatory properties of the IP~3~R (stimulation by IP~3~ and activation and delayed inhibition by \[Ca^2+^\]~i~) together with one of the above-mentioned feedback mechanisms ([Figure S5](#SD1){ref-type="supplementary-material"}).

In the absence of IP~3~ buffer, all models reproduce the experimentally observed encoding of agonist dose into \[Ca^2+^\]~i~ oscillation frequency ([Figures 5A--5D](#F5){ref-type="fig"}). This result shows that fundamentally different oscillator mechanisms can account for the data. However, the introduction of an IP~3~ buffer (at concentrations achieved for GFP-LBD; [Table S1](#SD1){ref-type="supplementary-material"}) reveals qualitative differences between the models. In the negative-feedback models (1 and 2), the IP~3~ buffer decreased oscillation frequency and increased the latency to first spike ([Figures 5E and 5F](#F5){ref-type="fig"}), but the oscillations persisted even at very high concentrations of IP~3~ buffer (30 μM). By contrast, in the positive-feedback model with Ca^2+^-activated PLC, IP~3~ buffer (5 μM) completely abolished oscillations. Instead, stepwise increases of \[Ca^2+^\]~i~ with increasing agonist concentrations were observed ([Figure 5G](#F5){ref-type="fig"}) that closely resemble the experimental observations in COS cells ([Figure 1](#F1){ref-type="fig"}). In this model, plasma-membrane Ca^2+^ fluxes were neglected, assuming that they are small relative to the fluxes across the ER membrane. When substantial Ca^2+^ fluxes through the plasma-membrane Ca^2+^ ATPase were added to the model, the IP~3~ buffer converted \[Ca^2+^\]~i~ oscillations into slow and broad responses to agonist stimulation ([Figure 5H](#F5){ref-type="fig"}) that are similar to those observed in hepatocytes ([Figure 2](#F2){ref-type="fig"}). For lower concentrations of IP~3~ buffer (\~1 μM), the oscillations persisted but had lower frequencies (not shown).

In summary, negative-feedback models involving either PKC or ITPK cannot account for the experimentally observed effects of GFP-LBD. By contrast, the positive-feedback model with Ca^2+^ activation of PLC reproduces the distinct patterns of broadened \[Ca^2+^\]~i~ oscillations and amplitude-modulated stepwise \[Ca^2+^\]~i~ increases observed in the presence of the IP~3~ buffer in hepatocytes and COS cells. This provides further evidence that IP~3~ dynamics are an intrinsic component of the Ca^2+^ oscillator, at least for these cell types.

DISCUSSION {#S10}
==========

We have used engineered IP~3~-binding proteins expressed in intact cells to investigate the effects of slowing \[IP~3~\] dynamics on hormone-induced \[Ca^2+^\]~i~ oscillations. Apart from possible effects on the initial Ca^2+^ spike, IP~3~ buffers are not expected to substantially affect \[Ca^2+^\]~i~ oscillator mechanisms that depend only on a static increase in \[IP~3~\] (e.g., CICR at the IP~3~R). By contrast, IP~3~ buffering is expected to perturb the ongoing generation of repetitive \[Ca^2+^\]~i~ spikes that depend on rapid modulation of IP~3~ levels to sustain the oscillatory behavior (e.g., cross-coupling between Ca^2+^ and IP~3~). Thus, IP~3~ buffers can be used as an experimental tool to examine the causality between IP~3~ dynamics and Ca^2+^ oscillations. Moreover, computational studies have shown that an IP~3~ buffer can be used to distinguish the type of Ca^2+^-dependent feedback (positive versus negative) on IP~3~ metabolism, because these mechanisms predict qualitatively different effects of IP~3~ buffering ([@R17]).

Expression of molecular IP~3~ buffers in hepatocytes and COS cells suppressed or eliminated oscillatory \[Ca^2+^\]~i~ signals in a concentration-dependent manner. The IP~3~R ligand-binding domain constructs used here did not directly affect intracellular Ca^2+^ release or plasma membrane Ca^2+^ entry mechanisms. The effects on \[Ca^2+^\]~i~ oscillations were specific for GFP-LBD binding to IP~3~ because the nonbinding mutant R265QLBD had no effect. Importantly, these IP~3~ buffering effects were not restricted to the initial phase of the oscillations but were observed for the first \[Ca^2+^\]~i~ spike and all of the subsequent spikes in the oscillation train. The fact that IP~3~ buffering affected these later Ca^2+^ oscillations is a clear indication of the importance of IP~3~ dynamics during ongoing Ca^2+^ spiking.

Simultaneous direct measurement of \[IP~3~\] and \[Ca^2+^\]~i~ revealed synchronized oscillations in both messengers during hormone stimulation. Importantly, the fact that the IP~3~ buffer slowed the rate of rise of both \[Ca^2+^\]~i~ and \[IP~3~\] indicates that Ca^2+^ dynamics are intimately tied to IP~3~ dynamics. Moreover, the effects of GFP-LBD cannot be explained by a reduction in the steady-state or time-averaged increase in free \[IP~3~\], because the peak \[IP~3~\] during each \[Ca^2+^\]~i~ spike was unaffected and the perturbation of \[Ca^2+^\]~i~ and \[IP~3~\] kinetics persisted throughout the train of oscillations. GFP-LBD also slowed the falling phase of each \[Ca^2+^\]~i~ oscillation, which is consistent with the expected interplay between Ca^2+^ and IP~3~ in the cross-coupling PLC positive feedback model ([@R17]). Thus, inactivation of the IP~3~R by Ca^2+^ negative feedback is insufficient to fully terminate Ca^2+^ release until the \[IP~3~\] falls, and this process is slowed by the presence of the IP~3~ buffer.

A slow, continuous photolysis of caged IP~3~ was used to mimic the low hormone doses that typically induce Ca^2+^ oscillations in hepatocytes. Although this slow IP~3~ uncaging could elicit a Ca^2+^ spike, the rates of Ca^2+^ rise were about 10-fold slower compared to those recorded after VP stimulation and also had a significantly lower amplitude. This can be explained by positive Ca^2+^ feedback on PLC only occurring during hormone activation, whereas the slow uncaging of IP~3~ in the absence of hormone does not engage this positive feedback on IP~3~ generation. Importantly, GFP-LBD did not affect the rate of rise or amplitude of Ca^2+^ increases triggered by the slow release of caged IP~3~, whereas subsequent hormone-evoked Ca^2+^ oscillations were inhibited in the same cell. These data indicate that the effects of GFP-LBD expression on hormone-induced Ca^2+^ oscillations are not a simple consequence of the rate of delivery of IP~3~ to the IP~3~R to trigger CICR. Instead, the qualitatively different effects of IP~3~ buffering observed with hormone compared to IP~3~ uncaging demonstrate the importance of positive feedback to regenerate IP~3~ during hormone stimulation and show that IP~3~ dynamics are an essential component sustaining baseline separated Ca^2+^ oscillations. Finally, our observation that hepatocytes and COS cells expressing high levels of GFP-LBD did not exhibit agonist-induced \[Ca^2+^\]~i~ oscillations at all but instead responded with monophasic or broad \[Ca^2+^\]~i~ transients indicates that \[Ca^2+^\]~i~ oscillations do not occur in these cells in the absence of \[IP~3~\] oscillations.

Taken together, the data are consistent with a model in which \[IP~3~\] oscillations, mediated by Ca^2+^-dependent feedback on IP~3~ metabolism, are essential for repetitive, large-amplitude \[Ca^2+^\]~i~ spiking. Cross-coupling between Ca^2+^ and IP~3~ can occur through either positive or negative feedback mechanisms. However, our experimental and computational studies indicate that the results can only be reproduced with a positive feedback mechanism, i.e., Ca^2+^-dependent activation of PLC. The IP~3~ buffer interferes by dampening and, at high concentration, abolishing the \[IP~3~\] oscillations. Accordingly, oscillatory \[Ca^2+^\]~i~ spikes are slowed and prolonged at low buffer concentration and disappear at high buffer concentration.

In conclusion, this study presents evidence that Ca^2+^ feedback regulation of the IP~3~R is not sufficient in itself to generate low-frequency, baseline-separated \[Ca^2+^\]~i~ oscillations elicited by PLC-linked hormones in hepatocytes and COS cells. Experimental manipulation of IP~3~ dynamics with an IP~3~ buffer has provided important insights into the mechanisms generating \[Ca^2+^\]~i~ oscillations and waves. Our data are consistent with a model for \[Ca^2+^\]~i~ spiking that combines IP~3~-Ca^2+^ cross-coupling with IP~3~R-based Ca^2+^ excitability. The combination of two coupled oscillators, one at the level of IP~3~ generation/breakdown and the other at the level of IP~3~R activation/inactivation, can greatly extend the frequency range for encoding hormone stimulus strength in \[Ca^2+^\]~i~ oscillations ([@R17]). This provides a high-fidelity signal, even at very low hormone doses, and is likely to be a widely used paradigm to fine-tune responses to stimulation.

EXPERIMENTAL PROCEDURES {#S11}
=======================

Cells {#S12}
-----

COS-7 cells obtained from American Type Culture Collection were cultured in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum. Hepatocytes were isolated by collagenase perfusion of rat livers and maintained in primary culture for 16--20 hr in Williams E medium ([@R8]; [@R18]). Animal studies were approved by Rutgers New Jersey Medical School Institutional Animal Care and Use Committee.

GFP-LBD Expression and IP~3~ Binding {#S13}
------------------------------------

Rat type 1 IP~3~R cDNA encoding LBD, residues 1--620, and R265QLBD were ligated in frame to the C terminus of pGFP-C1 or pDsRed-C1 (Clontech Laboratories) to generate the plasmids pGFP-LBD, pDsRed-LBD, and pGFP-R265QLBD. Cells were transfected 16--48 hr prior to use. Expression of recombinant protein was confirmed by western blot analysis with anti-GFP antibody. Confocal microscopy was used to calculate the intracellular \[GFP\] as described previously ([@R17]). Quantitation of IP~3~-binding sites in lysates of transfected COS cells was determined using \[^3^H\]-IP~3~ ([@R11]). Agonist-induced formation of IP~3~ in intact COS cells was measured using a commercial IP~3~ mass assay (GE Healthcare).

Ca^2+^ and IP~3~ Imaging {#S14}
------------------------

Live-cell imaging was performed with cells plated on glass coverslips. Fura-2 or Indo-1 were loaded as acetoxymethyl esters for 20--40 min. RGECO1 (Addgene) or IRIS-1 (gift of K. Mikoshiba, RIKEN Brain Science Institute) were cotransfected with the LBD constructs as required. The cells were incubated in HEPES-buffered physiological saline solution in a microscope chamber maintained at 37°C. Properties of \[Ca^2+^\]~i~ oscillations and waves were determined as described previously ([@R7]; [@R18], [@R19]).

Model Description {#S15}
-----------------

The mathematical models ([Figure S5](#SD1){ref-type="supplementary-material"}) used to compute the time courses of IP~3~ concentration, *P*; \[Ca^2+^ \]~i~, *c*; the free Ca^2+^ concentration in the ER, *s*; and the fraction of active IP~3~Rs, *r*, for the negative-feedback and positive-feedback-generated \[Ca^2+^\]~i~ spiking are described in the [Supplemental Information](#SD1){ref-type="supplementary-material"}.
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![Effects of GFP-LBD and GFP-R265QLBD on Agonist-Induced Ca^2+^ Signals in COS Cells\
COS cells transfected with GFP, GFP-LBD, or GFP-R265QLBD were loaded with fura-2 and then stimulated with ATP (arrowheads).\
(A--D) Traces are typical ATP-induced \[Ca^2+^\]~i~ responses in nonexpressing (A and C) and expressing (B and D) cells on the same coverslips.\
(E and F) The amplitude (E) and rate of rise (F) of \[Ca^2+^\]~i~ spikes induced by submaximal and maximal ATP are summarized for cells expressing GFP, GFP-LBD, or nonexpressing cells (none). Data are mean ± SEM from six separate experiments (n = 10--14 cells/group). \*p \< 0.05.\
(G--I) Bottom traces show \[Ca^2+^\]~i~ responses to stepwise increases in ATP in cells expressing nothing (G), GFP-LBD (H), or GFP-R265QLBD (I).](nihms-755256-f0002){#F1}

![Effects of GFP-LBD on Hormone-Induced Ca^2+^ Signals in Hepatocytes\
Hepatocytes transfected with GFP or GFP-LBD were loaded with fura-2.\
(A) VP-induced \[Ca^2+^\]~i~ increases in cells expressing GFP and low or high levels of GFP-LBD (\[GFP\] given under plots; see [Table S1](#SD1){ref-type="supplementary-material"} for mean data).\
(B) Percentage of cells showing the indicated Ca^2+^ response to submaximal hormone; n = 6 cell preparations.\
(C) Mean width of VP-induced \[Ca^2+^\]~i~ spikes at half peak height as a function of \[GFP\].\
(D) Green and red traces show \[Ca^2+^\]~i~ spikes at proximal and distal subcellular regions along the Ca^2+^ wave-propagation vector during 2 nM VP stimulation; vector lengths were 15.5 mm (i), 16.8 mm (ii), and 19.2 mm (iii). Fluorescence was normalized to initial and peak intensity.\
(E and F) Effects of GFP-LBD on rates of Ca^2+^ wave propagation and \[Ca^2+^\]~i~ rise in response to submaximal and maximal hormone. Data are mean ± SEM (six cell preparations). \*Significantly different from GFP-expressing cells; black diamond, significantly different from GFP and low-GFP-LBD-expressing cells; p \< 0.05.](nihms-755256-f0003){#F2}

![Effect of GFP-LBD on \[Ca^2+^\]~i~ Response to Slow Uncaging of IP~3~\
(A and B) Hepatocytes cotransfected with RGECO1 and either GFP (A) or GFP-LBD (B) were loaded with caged IP~3~ (2 μM; 1 hr). The gray area shows the duration of slow IP~3~ uncaging elicited by low-intensity UV illumination (50 ms exposures at 2 Hz). VP was added at the arrow 5 min after stopping UV illumination.\
(C--E) Summary of the effects of GFP and GFPLBD on the rate of Ca^2+^ rise (C), peak amplitude (D), and spike width (E). Data are mean ± SEM (n R 50 cells from four separate experiments). \*Significantly different from GFP-expressing cells (p \< 0.05); ^\#^significantly different from control (GFP) VP response; p \< 0.05.](nihms-755256-f0004){#F3}

![Effect of LBD on \[Ca^2+^\]~i~ and IP~3~ Dynamics in Hepatocytes\
Hepatocytes cotransfected with IRIS-1 and either DsRed or DsRed-LBD were loaded with Indo-1 and then stimulated with submaximal (1--5 nM VP) or maximal (100 nM VP or 100 μM ATP) agonist.\
(A) Simultaneous measurement of IP~3~ and \[Ca^2+^\]~i~ oscillations.\
(B) Expanded time course of single IP~3~ and \[Ca^2+^\]~i~ transients in the presence of DsRed or DsRed-LBD.\
(C and D) Kinetics of VP-induced \[Ca^2+^\]~i~ oscillations in cells expressing IRIS-1 plus DsRed (*DsRed*) or IRIS-1 plus DsRed-LBD (*LBD*), compared to nonexpressing cells on the same coverslips (*None*).\
(E and F) Effect of DsRed-LBD on the rate and magnitude of IP~3~ formation measured with IRIS-1 in cells stimulated with submaximal and maximal agonist. Data are mean ± SEM; n = 4--7 cells from five separate experiments. \*Significantly different from nonexpressing cells; black diamond, significantly different from DsRed and nonexpressing cells; black triangle, significantly different from DsRed-expressing cells; p \< 0.05.](nihms-755256-f0005){#F4}

![Simulations of the Effect of GFP-LBD Expression in Mathematical Models of Ca^2+^/IP~3~ Oscillations\
Ca^2+^ and IP~3~ oscillations were modeled as described in [Supplemental Information](#SD1){ref-type="supplementary-material"} in the absence (A--D) and presence (E--H) of LBD IP~3~ buffer. Parameters used are given in [Table S2](#SD1){ref-type="supplementary-material"}. Stepwise agonist dose increases occur at each arrow. All models show frequency encoding of stimulus strength in the absence of LBD. LBD does not abolish oscillations in models with PKC-mediated receptor/PLC inactivation (E) or Ca^2+^-dependent IP~3~ metabolism by ITPK (F). Ca^2+^ oscillations are abolished by LBD in models with Ca^2+^ activation of PLC (G and H). Graded plateau \[Ca^2+^\]~i~ increases occur when the plasma membrane fluxes are neglected (G), and slow broad \[Ca^2+^\]~i~ transients occur when Ca^2+^ fluxes through the PMCA are substantial (H). LBD concentrations were 30 μM in (E), (F), and (H) and 5 mM in (G).](nihms-755256-f0006){#F5}

###### Highlights

Ca^2+^ oscillation mechanisms can be distinguished using an IP~3~ buffer

IP~3~ buffer suppresses IP~3~ oscillations without decreasing peak levels of IP~3~ or Ca^2+^

IP~3~ buffering slows Ca^2+^ oscillation kinetics and reduces Ca^2+^ wave-propagation rates

Ca^2+^ oscillations in hepatocytes are driven by Ca^2+^ feedback on IP~3~ formation
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